Literature DB >> 7968026

The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies.

P Amouyel1, O Vidal, J M Launay, J L Laplanche.   

Abstract

Creutzfeldt-Jakob disease (CJD) is a rapid progressive mental and neurological disorder characterised by dementia and is both infectious and genetic. Pathogenic mutations and a predisposing polymorphism have been described in the prion protein gene and an abnormal prion product accumulates in the brain of affected patients. Apolipoprotein E (APOE), a protein of lipid metabolism, has been detected in some prion protein deposits. This ApoE exists as three common isoforms, coded by specific allele (epsilon 2, epsilon 3, epsilon 4). The presence of at least one epsilon 4 allele was described as a major risk factor for Alzheimer's disease, another neurodegenerative disorder. From a series of 61 patients with CJD we found that epsilon 4 allele of the APOE gene was a risk factor for the disease (p < 0.01). This association was observed in both definite and probable cases, and for patients with and without prion protein gene mutations. Moreover, in affected subjects, epsilon 2 allele of the APOE gene delayed occurrence of death (p < 0.01) independently of other known mutations influencing the phenotype of the disease. These effects on neurodegenerative disease associated with APOE alleles suggest a strong involvement of the APOE locus in brain metabolism.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7968026     DOI: 10.1016/s0140-6736(94)90691-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Authors:  S Danet; T Brousseau; F Richard; P Amouyel; C Berr
Journal:  J Epidemiol Community Health       Date:  1999-07       Impact factor: 3.710

Review 2.  Epidemiology of the dementias: recent developments and new approaches.

Authors:  C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  RARB and STMN2 polymorphisms are not associated with sporadic Creutzfeldt-Jakob disease (CJD) in the Korean population.

Authors:  Byung-Hoon Jeong; Hae-Jung Kim; Kyung-Hee Lee; Richard I Carp; Yong-Sun Kim
Journal:  Mol Biol Rep       Date:  2014-01-12       Impact factor: 2.316

Review 4.  Apolipoprotein E in Alzheimer's disease and other neurological disorders.

Authors:  Philip B Verghese; Joseph M Castellano; David M Holtzman
Journal:  Lancet Neurol       Date:  2011-03       Impact factor: 44.182

5.  Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene.

Authors:  S Spudich; J A Mastrianni; M Wrensch; R Gabizon; Z Meiner; I Kahana; H Rosenmann; E Kahana; S B Prusiner
Journal:  Mol Med       Date:  1995-09       Impact factor: 6.354

6.  Disease duration in E200K familial Creutzfeldt-Jakob disease is correlated with clinical, radiological, and laboratory variables.

Authors:  Oren S Cohen; Joab Chapman; Amos D Korczyn; Zeev Nitsan; Shmuel Appel; Esther Kahana; Hanna Rosenmann; Chen Hoffmann
Journal:  J Neural Transm (Vienna)       Date:  2018-11-29       Impact factor: 3.575

7.  ApoE distribution and family history in genetic prion diseases in Germany.

Authors:  Anna Krasnianski; Nicolas von Ahsen; Uta Heinemann; Bettina Meissner; Hans A Kretzschmar; Victor W Armstrong; Inga Zerr
Journal:  J Mol Neurosci       Date:  2007-09-11       Impact factor: 3.444

8.  Lack of association between schizophrenia and the apolipoprotein E epsilon 4 allele.

Authors:  E Jönsson; L Lannfelt; B Engvall; G Sedvall
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

Review 9.  Can infections cause Alzheimer's disease?

Authors:  Francis Mawanda; Robert Wallace
Journal:  Epidemiol Rev       Date:  2013-01-24       Impact factor: 6.222

10.  Genetic association of apolipoprotein E with age-related macular degeneration.

Authors:  C C Klaver; M Kliffen; C M van Duijn; A Hofman; M Cruts; D E Grobbee; C van Broeckhoven; P T de Jong
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.